Transaction overview
NewPrinces, an Italian food and beverage company, completed its acquisition of Plasmon from Kraft Heinz on December 31, 2025, for €124.3 million in cash. The deal includes a leaseback agreement between Plasmon and Princes Italia regarding the Latina production facility. Announced on July 9, 2025, this acquisition consolidates NewPrinces' position in Italy and Europe within the infant food and specialized nutrition sectors.
Deal structure and financing
The transaction was entirely financed with cash, provided by BNP Paribas and Monte dei Paschi di Siena as lead banks. No debt or equity was raised for the deal. The leaseback agreement between Plasmon and Princes Italia includes an annual rent of €3 million plus 1.5% of business revenue generated from operations at the Latina facility, with a three-year term renewable by Princes Italia. There were no IPO options discussed in this transaction.
Strategic context
NewPrinces aimed to strengthen its market position through the acquisition of Plasmon's portfolio of infant food and specialized nutrition products, including well-known brands such as Plasmon, Nipiol, BiAglut, Aproten, and Dieterba. For Kraft Heinz, this divestiture aligns with its strategy to focus on core growth platforms like HEINZ Tomato Ketchup in Italy's "Taste Elevation" category, while NewPrinces views the acquisition as a long-term strategic move to enhance value for all stakeholders through synergies and operational efficiencies.
Regulatory path
The acquisition was reviewed by Italian competition authorities due to its size and the involved parties' market presence. No specific regulatory remedies were required, and the transaction proceeded smoothly with filings made under the HSR Act in Italy. Given the deal's nature within the European Union, EU regulators likely monitored the transaction as well, though no public remedial actions or delays have been reported.